GrunbergerG, HandelsmanY, BloomgardenZT, et al.American Association of Clinical Endocrinologists and American College of Endocrinology 2018 position statement on integration of insulin pumps and continuous glucose monitoring in patients with diabetes mellitus. Endocr Pract, 2018; 24: 302–308.
MesserLH, JohnsonR, DriscollKA, JonesJ. Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with type 1 diabetes. Diabet Med, 2018; 35: 409-418.
6.
VescoAT, JedraszkoAM, GarzaKP, Weissberg-BenchellJ. Continuous glucose monitoring associated with less diabetes-specific emotional distress and lower A1c among adolescents with type 1 diabetes. J Diabetes Sci Technol, 2018; 12: 792–799.
7.
LittleSA, SpeightJ, LeelarathnaL, et al.Sustained reduction in severe hypoglycemia in adults with type 1 diabetes complicated by impaired awareness of hypoglycemia: 2-year follow-up in the HypoCOMPaSS randomized clinical trial. Diabetes Care, 2018; 41: 1600–1607.
8.
FoxLA, HersheyT, MaurasN, et al; Diabetes Research in Children Network (DirecNet). Persistence of abnormalities in white matter in children with type 1 diabetes. Diabetologia, 2018; 61: 1538–1547.
9.
LacyME, GilsanzP, KarterAJ, QuesenberryCP, PletcherMJ, WhitmerRA. Long-term glycemic control and dementia risk in type 1 diabetes. Diabetes Care, 2018 Sep 4; pii: dc180073. DOI: 10.2337/dc18-0073 [Epub ahead of print].
10.
ChaytorNS, Barbosa-LeikerC, RyanCM, GermineLT, HirschIB, WeinstockRS. Clinically significant cognitive impairment in older adults with type 1 diabetes. J Diabetes Complications, 2018 Apr 14; pii: S1056-8727(18)30109-0.DOI 10.1016/j.jdiacomp.2018.04.003 [Epub ahead of print].
11.
ÓlafsdóttirAF, PolonskyW, BolinderJ, et al.A randomized clinical trial of the effect of continuous glucose monitoring on nocturnal hypoglycemia, daytime hypoglycemia, glycemic variability, and hypoglycemia confidence in persons with type 1 diabetes treated with multiple daily insulin injections (GOLD-3). Diabetes Technol Ther, 2018; 20: 274–284.
12.
OskarssonP, AntunaR, Geelhoed-DuijvestijnP, KrögerJ, WeitgasserR, BolinderJ. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial. Diabetologia, 2018; 61: 539–550.
13.
MurphyHR. Intensive glycemic treatment during type 1 diabetes pregnancy: a story of (mostly) sweet success!. Diabetes Care, 2018; 41: 1563–1571.
14.
AbellSK, ZoungasS. Real-time continuous glucose monitoring improves glycaemic variability and neonatal outcomes in pregnant women with type 1 diabetes. BMJ Evid Based Med, 2018; 23: 156–157.
15.
KropffJ, ChoudharyP, NeupaneS, et al.Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE Study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care, 2017; 40: 63–68.
16.
BarnardKD, KropffJ, ChoudharyP, et al.Acceptability of implantable continuous glucose monitoring sensor. J Diabetes Sci Technol, 2018; 12: 634–638.
17.
ChauguleS, OliverN, KlinkenbijlB, GrahamC. An economic evaluation of continuous glucose monitoring for people with type 1 diabetes and impaired awareness of hypoglycaemia within North West London clinical commissioning groups in England. Eur Endocrinol, 2017; 13: 81–85.
18.
GillM, ZhuC, ShahM, ChhabraH. Health care costs, hospital admissions, and glycemic control using a standalone, real-time, continuous glucose monitoring system in commercially insured patients with type 1 diabetes. J Diabetes Sci Technol, 2018; 12: 800–807.
19.
CongetI, Martín-VaqueroP, RozeS, ElíasI, PinedaC, ÁlvarezM, DelbaereA, Ampudia-BlascoFJ. Cost-effectiveness analysis of sensor-augmented pump therapy with low glucose-suspend in patients with type 1 diabetes mellitus and high risk of hypoglycemia in Spain. Endocrinol Diabetes Nutr, 2018; 65: 380–386.
20.
LeelarathnaL, WilmotEG. Flash forward: a review of flash glucose monitoring. Diabet Med, 2018; 35: 472–482.
